AFT Pharmaceuticals Limited Appoints Louise Clayton as New Director of International Business, Effective from November 2017; Announces New Loan Facility with Capital Royalty Group
Under its existing loan facility (April 2014) with Capital Royalty Group (CRG), the company drew down $15 million of the $30 million full facility. The ability to make additional draw- downs expired in October 2016. AFT and CRG have agreed to a new loan facility of up to $10 million, $5 million of which is a mandatory drawdown prior to 31 March 2018. It was also agreed that the repayments for all facilities will not be required to be made before maturity on 31
March 2020. The terms of the existing facilities provided by CRG is amended to provide the option that no repayments are required before that date. Interest and fees for the new loan are the same as for the existing facilities provided by CRG.